Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCSRT.L Share News (CSRT)

  • There is currently no data for CSRT

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

WINNERS & LOSERS SUMMARY: Domino's Pizza Slumps As Profit Falls

Tue, 07th Aug 2018 10:37

LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices on Tuesday.----------FTSE 100 - WINNERS----------Standard Life Aberdeen, up 2.6%. The investment manager's shares were higher despite reporting a drop in first half earnings as net fund outflows continued. Standard Life Aberdeen recorded assets under management and administration from continuing operations of GBP610.10 billion as at June 30, down 2.6% from GBP626.50 billion as at December 31. Net fund outflows from continuing operations totalled GBP16.60 billion versus GBP12.40 billion outflows recorded in the comparative year ago period. Adjusted pretax profit from continuing operations - a key profit measure for the company - for the interim period totalled GBP311 million, down 12% than GBP355 million recorded a year ago. The drop was attributed to lower fee-based revenue, which reduced by 7% to GBP966 million. The company said continues to make good progress on its integration programme and is now targeting over GBP350 million in savings.----------FTSE 100 - LOSERS----------Intertek, down 5.6%. The testing, inspection and certification services provider said it remains well positioned to deliver good organic revenue growth, moderate margin progression at constant currency and strong cash conversion for the full year after reporting a modest increase in interim profit. The company recorded pretax profit of GBP196.6 million for the six months to June 30, up from GBP190.6 million in the year ago period, on a revenue of GBP1.35 billion and GBP1.37 billion, respectively. The rise in profit was attributed to higher operating margins, which stood at 16.8% versus 16.3%, resulting from positive operating leverage, margin accretive divisional mix, portfolio review and margin accretive acquisitions. The slide in first half revenue was due to appreciation of sterling against most of the company's trading currencies. ----------Hargreaves Lansdown, down 3.4%. The fund supermarket's shares were lower despite reporting an increased annual profit due to more-active client share dealing, an increase in new business, and net asset growth. In its financial year ended June 30, the company recorded a GBP292.4 million pretax profit, up 10% from GBP265.8 million the year before. Hargreaves' total net revenue was GBP447.5 million, a 16% increase from GBP385.6 million a year before, and a strong contributor to profit. Total assets under administration at June end stood at GBP91.6 billion, a 16% increase from GBP79.2 billion the previous year. "Brexit is on the horizon and the prevailing political and economic turbulence is having an effect on investor confidence. However...I believe the strength and scale of our business means we can continue to develop our offering to the benefit of all our stakeholders in the future," said Hargreaves Chief Executive Chris Hill.----------Ocado Group, down 1.7%. Barclays downgraded the online grocer to Underweight from Equal Weight.----------FTSE 250 - WINNERS----------Ferrexpo, up 4.1%. JPMorgan upgraded the iron pellet producer to Overweight from Neutral. ----------FTSE 250 - LOSERS----------Domino's Pizza, down 11%. The pizza chain's revenue climbed 23% in the first half of the year, helped by a good international performance, but costs associated with that international arm sent pretax profit down 9.7%. For the six months to July 1, Domino's Pizza posted revenue up to GBP259.1 million from GBP211.3 million year-on-year. Pretax profit fell to GBP41.7 from GBP46.2 reported a year ago as high wages in Norway hiked administrative costs to GBP52.7 million from GBP30.6 million year-on-year. In the UK, Domino's said that the trading environment "continues to be uncertain". The chain opened 22 new stores in the first-half taking the total number to 1,067. Domino's said it expects to open 60 more stores in the UK in 2018. ----------Ultra Electronics, down 9.7%. Kepler Cheuvreux downgraded the defence company to Hold from Buy.----------OTHER MAIN MARKET AND AIM - WINNERS----------Harvey Nash Group, up 17% at 130.15 pence. The recruiter said it has agreed a takeover by shareholder DBAY Advisors worth GBP98.7 million. The Power of Talent, which is a new entity set up by DBAY, has offered 130 pence per share for each Harvey Nash share, plus an interim dividend from Harvey Nash of 1.75p per share. This offer, Harvey Nash said, is a 92% premium to its closing price on March 6, 2017, the day before DBAY announced it had a significant holding in Harvey Nash. It currently has a 26% stake, making it the recruitment firm's biggest shareholder.----------OTHER MAIN MARKET AND AIM - LOSERS----------Carclo, down 18%. Shares in the plastics supplier fell after medical devices manufacturer Consort Medical said it does not intend to make an offer for Carclo. "Further to meetings between Consort and Carclo, and after careful consideration, the board of Consort has determined that the proposed transaction would not deliver the required benefits in a reasonable timeframe and it is therefore not in the interests of its shareholders to continue with a non-binding proposal for Carclo," Consort said in a statement. In response to Consort's withdrawal, Carclo said it remains highly confident in its prospects and standalone strategy. Carclo earlier in July rejected an initial merger proposal from Consort Medical, which subsequently submitted a revised offer for Carclo. ----------
More News
3 Jan 2017 08:10

Consort Medical splutters as BAT stubs out Voke programme

(ShareCast News) - British American Tobacco has terminated an agreement with Consort Medical over the manufacture of nicotine inhalers for its Voke development programme. Consort, which said it was in "constructive dialogue" with BAT's Nicovations arm and product developer Kind Consumer over the fut

Read more
6 Dec 2016 08:18

Consort Medical posts good growth in first half

(ShareCast News) - Single source drug and delivery device company Consort Medical announced its interim results for the six months to 31 October on Tuesday. The London-listed firm said group revenue increased to £144.9m from £135.5m, representing underlying growth of 2.0% and reported growth of 6.9%

Read more
25 Nov 2016 09:07

Consort Medical appoints new CFO

(ShareCast News) - Consort Medical, a global provider of manufacturing solutions for drugs, announced that it has appointed Paul Hayes as group Finance Director of the Vitec Group. Hayes is taking over the position of chief financial officer from Richard Cotton as well joining the board as executive

Read more
27 Oct 2016 07:45

Consort Medical Welcomes Cimzia Autoclicks Launch On NHS

Read more
14 Oct 2016 12:23

Consort Medical's Bespak inks new agreement

(ShareCast News) - Consort medical, a global single source drug and Delivery device company (CDMO), has announced that its Bespak division has entered into an agreement with a biopharmaceutical company. Bespak manufactures drug delivery devices for pharmaceutical partner companies including respirat

Read more
19 Sep 2016 09:07

Consort Notes European Nod For Bespak Technology-Using Product

Read more
7 Sep 2016 08:43

Consort Medical signs agreement with AstraZeneca

(ShareCast News) - Consort medical, a provider of advanced technology for drugs, has signed a new contract with pharmaceutical giant AstraZeneca for the supply of its Bespak respiratory devices. AstraZeneca and Bespak have agreed to enter into a multi-year agreement for the scale-up and supply of Be

Read more
7 Sep 2016 07:03

Consort Medical Sees Little Brexit Impact; Signs Deal With AstraZeneca

Read more
23 Jun 2016 15:19

Director dealings: Derwent London CEO sells just ahead of Brexit vote

(ShareCast News) - Derwent London chief executive John Burns has sold £1.5m of the FTSE 250 real estate investor's shares in the week just before the EU referendum which could seriously lift or undermine the company's shares. In Wednesday's sale, which comes two days before results for Britain's ref

Read more
17 Jun 2016 09:29

Numis places Consort Medical 'under review'

(ShareCast News) - Consort Medical's shares were put 'under review' by Numis after the company reported its full year results. The pharmaceutical device frim on Thursday reported full year earnings before interest and tax rose 47.6% to £37m as revenues gained 49.8% to £276.9m, driven by a strong per

Read more
16 Jun 2016 14:52

Consort Medical's annual revenues rise as a product launch is delayed

(ShareCast News) - Consort Medical, a pharmaceutical device company, revealed higher full year profits on Thursday due to organic growth and an acquisition. Revenues rose 49.8% to £276.9m from £184.8m the previous financial year. Bespak, the company's drug device manufacturing subsidiary, continued

Read more
16 Jun 2016 07:37

Consort Medical Profit Doubles As Progress Made On DEV610 Programme

Read more
9 Jun 2016 15:04

UK Earnings, Trading Statements Calendar - Next 7 Days

Read more
5 Apr 2016 08:32

BROKER RATINGS SUMMARY: Liberum Upgrades Babcock To Hold From Sell

Read more
22 Feb 2016 16:51

Consort Medical agrees partnership and invests in Precision Ocular

(ShareCast News) - Consort Medical has made a £3.3m equity investment for a 13.7% stake in retinal therapeutics specialist Precision Ocular and agreed a development and manufacturing partnership. London-based Precision Ocular has developed retinal treatments that are designed to access specific sma

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.